PARAMETER | Group A (n=25) | Group B (n=24) | p-value | ||
---|---|---|---|---|---|
N | % | N | % | ||
Gender | |||||
Male | 17 | 68 | 17 | 70.8 | NS# |
Female | 8 | 32 | 7 | 29.2 | |
Age | |||||
Mean | 62.8 | 56.6 | NS+ | ||
Range | 42-83 | 24-78 | |||
Tumor histological diagnosis | |||||
Scca | 14 | 56 | 11 | 45.8 | NS# |
Npca | 6 | 24 | 9 | 37.5 | |
Other | 5 | 20 | 4 | 16.7 | |
Tumor stage> ( N=24) | |||||
T1 | 1 | 4.2 | 4 | 16.7 | NS* |
T2 | 18 | 75 | 11 | 45.8 | |
T3 | 1 | 4.2 | 4 | 16.7 | |
T4 | 2 | 8.3 | 4 | 16.7 | |
Tx | 2 | 8.3 | 1 | 4.2 | |
Node stage (N=24) | |||||
N0 | 2 | 8.3 | 8 | 33.3 | p=0.03* |
N1 | 12 | 50 | 7 | 29.2 | |
N2 | 10 | 41.7 | 6 | 25 | |
N3 | 0 | 0 | 3 | 12.5 | |
Nx | 0 | 0 | 0 | 0 | |
Type of RT | |||||
Radical | 14 | 56 | 11 | 45.8 | NS# |
Postoperative | 11 | 44 | 13 | 54.2 | |
Daily dose | |||||
1.8Gy | 17 | 68 | 3 | 12.5 | p<0.003* |
2.0Gy | 8 | 32 | 20 | 83.3 | |
2.4Gy | 0 | 0 | 1 | 4.2 | |
Total dose | |||||
Mean | 65.6 | 64.6 | NS* | ||
Range | 59.4-72 | 46-70 |